Hi,
moomoo ID:NaN
Log Out
English
Back
Download
Log in to access Online Inquiry
Quotes
Detailed Quotes
Company Overview
Company ProfileCompany Executives
Financial Analysis
Main CompositionKey IndicatorsFinancial Statement
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > TALS Talaris Therapeutics > Detailed Quotes

TALS Talaris Therapeutics

Watchlist
1.720
+0.090+5.52%
Close  02/06 16:00 ET
1.7200.0000.00%
Post Mkt Price 02/06 16:01 ET
High
1.730
Open
1.650
Turnover
256.48K
Low
1.650
Pre Close
1.630
Volume
152.39K
Market Cap
71.76M
P/E(TTM)
Loss
52wk High
10.560
Shares
41.72M
P/E(Static)
Loss
52wk Low
0.890
Float Cap
22.28M
Bid/Ask %
50.00%
Historical High
19.820
Shs Float
12.96M
Volume Ratio
0.20
Historical Low
0.890
Dividend TTM
--
Div Yield TTM
--
P/B
0.37
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.18%
Amplitude
4.91%
Avg Price
1.683
Lot Size
1
Float Cap
22.28M
Bid/Ask %
50.00%
Historical High
19.820
Shs Float
12.96M
Volume Ratio
0.20
Historical Low
0.890
Dividend TTM
--
P/B
0.37
Dividend LFY
--
Turnover Ratio
1.18%
Amplitude
4.91%
Avg Price
1.683
Lot Size
1
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast

News

Comment

News

Announcement

No Data

Company Overview More
Talaris Therapeutics, Inc. engages in cell therapy. It develops methods of allogeneic hematopoietic stem cell transplantation (allo-HSCT). Its technologies are used to treat inherited metabolic enzyme disorders, red blood cell disorders to induce tolerance to organ transplants, and to treat autoimmune disorders such as type 1 diabetes, multiple sclerosis, rheumatoid arthritis, and scleroderma. The company was founded by Suzanne Ildstad on February 15, 2002 and is headquartered in Louisville, KY.
CEO： Mr. Scott Requadt
Market： NASDAQ
Listing Date： 05/07/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Get Started
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist